Home > Insider Trading > Filing (0001225208-21-003526)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1529751	A David Pierce	300 Boston Scientific Way Marlborough MA 01752-1234	Evp Pres Medsurg	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-02-19	1,484	$38.00	9,660	No	4	S	Direct
Common Stock	Acquisiton	2021-02-21	2,492	$0.00	12,152	No	4	M	Direct
Common Stock	Disposition	2021-02-21	1,106	$38.03	11,046	No	4	F	Direct
Common Stock	Acquisiton	2021-02-22	2,607	$0.00	13,653	No	4	M	Direct
Common Stock	Disposition	2021-02-22	1,157	$39.20	12,496	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Deferred Stock Units	Disposition	2021-02-21	2,492	$0.00	2,492	$0.00
Common Stock	Deferred Stock Units	Disposition	2021-02-22	2,607	$0.00	2,607	$0.00
Common Stock	Performance Share Units	Acquisiton	2021-02-22	9,456	$0.00	9,456	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,986		2023-02-21	No	4	M	Direct
0		2021-02-22	No	4	M	Direct
9,456	2022-12-31	2022-12-31	No	4	A	Direct

Footnotes

This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
On February 18, 2020, the reporting person was awarded a target number of performance share units under the Company's 2020 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2020 adjusted free cash flow measured against its 2020 financial plan over the one-year performance period ending December 31, 2020 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2022.